• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>C.R. Bard

C.R. Bard

C.R. Bard Inc BCR

Last Price$223.73Day Change (%)-0.23%
Open Price$223.86Day Change ($)-0.52
Day Range223.07–225.0052-Week Range172.21–239.43

As of Fri 7/29/2016 5:34:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Global Intravenous Equipment Strategic Business Report 2015-2022 - Smart Infusion Systems: Marking the Convergence of Healthcare IT & IV Drug Delivery Systems - Research and Markets

    Global Intravenous Equipment Strategic Business Report 2015-2022 - Smart Infusion Systems: Marking the Convergence of Healthcare IT & IV Drug Delivery Systems - Research and Markets

  2. United States Market Report for Urinary Incontinence Devices 2016 - Research and Markets

    United States Market Report for Urinary Incontinence Devices 2016 - Research and Markets

  3. World Temperature Management Market Report 2016 - Opportunities and Forecasts to 2022 - Research and Markets

    World Temperature Management Market Report 2016 - Opportunities and Forecasts to 2022 - Research and Markets

  4. Ideal Standard International S.A.: Appointment of Zubair Javeed as Chief Financial Officer and Executive Management Team member

    Ideal Standard International S.A.: Appointment of Zubair Javeed as Chief Financial Officer and Executive Management Team member

  5. Our Outlook for Health-Care Stocks

    Med-tech multinationals look to the East for growth in China.

  6. The Nine Best New Funds of 2010

    Some promising ideas for your 2011 watchlist.

  7. Our Ultimate Stock-Pickers' Top 10 Buys and Sells

    We saw a higher level of trading by our top managers in the most recent period.

  8. Four Ultimate Stock-Pickers That Continue to Outperform

    Market volatility has shaped the performance of many top managers this year.

  9. How Will Health-Care Reform Impact These Funds?

    Some great funds see attractive opportunities in the health-care sector.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.